Bo Jin

615 total citations
31 papers, 466 citations indexed

About

Bo Jin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Bo Jin has authored 31 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Bo Jin's work include Cardiovascular Function and Risk Factors (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Bo Jin is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Bo Jin collaborates with scholars based in China, South Korea and Finland. Bo Jin's co-authors include Xingyi Li, Yan Liu, Haijiang Wang, Yi Wang, Lijiang Huang, Dan Lin, Ailing Yu, Lei Lei, Yuhan Hu and Hui Shi and has published in prestigious journals such as PLoS ONE, Chemical Engineering Journal and Cell Death and Differentiation.

In The Last Decade

Bo Jin

30 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Jin China 14 199 57 51 51 39 31 466
You Li China 12 250 1.3× 51 0.9× 103 2.0× 46 0.9× 34 0.9× 29 598
Lamia Heikal Egypt 14 142 0.7× 24 0.4× 62 1.2× 50 1.0× 33 0.8× 45 493
Qianmei Wang China 13 147 0.7× 70 1.2× 38 0.7× 42 0.8× 25 0.6× 31 401
Yu Su China 12 199 1.0× 64 1.1× 24 0.5× 60 1.2× 17 0.4× 17 405
Mohammad Arshad Javed Shaikh India 10 227 1.1× 65 1.1× 80 1.6× 98 1.9× 37 0.9× 17 535
Sadat Dokaneheifard United States 10 247 1.2× 43 0.8× 36 0.7× 97 1.9× 18 0.5× 13 506
Muhammad Zaeem China 9 215 1.1× 53 0.9× 20 0.4× 28 0.5× 53 1.4× 10 369
Xue Fan China 14 129 0.6× 47 0.8× 34 0.7× 19 0.4× 72 1.8× 28 448
Caixia Lin China 12 171 0.9× 76 1.3× 38 0.7× 37 0.7× 24 0.6× 17 473

Countries citing papers authored by Bo Jin

Since Specialization
Citations

This map shows the geographic impact of Bo Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Jin more than expected).

Fields of papers citing papers by Bo Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Jin. The network helps show where Bo Jin may publish in the future.

Co-authorship network of co-authors of Bo Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Jin. A scholar is included among the top collaborators of Bo Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Jin. Bo Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jiong, Bo Jin, Yi Chen, et al.. (2024). Costunolide attenuates high‐fat diet‐induced inflammation and oxidative stress in non‐alcoholic fatty liver disease. Drug Development Research. 85(1). e22150–e22150. 3 indexed citations
3.
Wang, Jiong, Chenchen Qian, Jianjun Lin, et al.. (2024). Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease. Nutrition and Diabetes. 14(1). 41–41. 7 indexed citations
4.
Jin, Bo, et al.. (2024). Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in inflammatory bowel disease by targeting TLR2. Toxicology and Applied Pharmacology. 486. 116922–116922. 4 indexed citations
5.
Qian, Chenchen, Jiong Wang, Yue Luo, et al.. (2024). Toll-like receptor 2 deficiency ameliorates obesity-induced cardiomyopathy via inhibiting NF-κB signaling pathway. International Immunopharmacology. 128. 111551–111551. 3 indexed citations
6.
Jin, Bo, Jiong Wang, Wei Zuo, et al.. (2023). Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy. International Immunopharmacology. 120. 110280–110280. 4 indexed citations
7.
Jin, Bo, Rieko Oyama, Yoko Tabe, et al.. (2023). Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan. Frontiers in Microbiology. 14. 1229234–1229234. 1 indexed citations
8.
Liu, Xin, Yi Fang, Guo‐Rong Chen, et al.. (2023). Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death and Differentiation. 30(6). 1457–1471. 51 indexed citations
9.
Liu, Yixiao, Bo Jin, Cheng Shen, et al.. (2023). Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients. Frontiers in Oncology. 13. 1086517–1086517. 3 indexed citations
10.
Wang, Jiong, Chenchen Qian, Yue Chen, et al.. (2023). β-elemene alleviates hyperglycemia-induced cardiac inflammation and remodeling by inhibiting the JAK/STAT3-NF-κB pathway. Phytomedicine. 119. 154987–154987. 16 indexed citations
11.
Zhang, Lingxi, Bo Jin, Bin Bai, et al.. (2023). Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress. Cardiovascular Drugs and Therapy. 38(3). 555–568. 2 indexed citations
12.
Jin, Bo, et al.. (2023). Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress. Journal of Cellular and Molecular Medicine. 27(6). 831–845. 13 indexed citations
13.
Jin, Xiaoliang, et al.. (2023). Opportunistic colonoscopy in healthy individuals: A non-trivial risk of adenoma. PLoS ONE. 18(4). e0283575–e0283575. 1 indexed citations
14.
Liu, Zhenzhen, et al.. (2023). Evaluation of myopia-associated genes in a Han Chinese population with high myopia. Ophthalmic Genetics. 44(4). 341–345. 5 indexed citations
15.
Zou, Min, Jiawen Li, Bo Jin, et al.. (2021). Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Bioorganic Chemistry. 114. 105200–105200. 16 indexed citations
16.
Jiang, Song, Qingyan Zhang, Bo Jin, et al.. (2021). Integrin β3 Induction Promotes Tubular Cell Senescence and Kidney Fibrosis. Frontiers in Cell and Developmental Biology. 9. 733831–733831. 18 indexed citations
17.
Chai, Chuan, Bo Jin, Yuan Qi, et al.. (2020). Anti-depressant effect of Zhi-zi-chi decoction on CUMS mice and elucidation of its signaling pathway. Journal of Ethnopharmacology. 266. 113283–113283. 26 indexed citations
18.
Wu, Xuangao, Bo Jin, Hye Jeong Yang, Min Jung Kim, & Sunmin Park. (2019). A mixture of blackberry leaf and fruit extracts decreases fat deposition in HepG2 cells, modifying the gut microbiome. Journal of Applied Biological Chemistry. 62(3). 229–237. 2 indexed citations
19.
Jin, Bo, Yan Liu, & Haijiang Wang. (2015). Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel. Cell Biochemistry and Biophysics. 72(1). 275–282. 33 indexed citations
20.
Jin, Bo, Songming Huang, Yanggang Yuan, et al.. (2012). Insulin resistance in children with primary nephrotic syndrome and normal renal function. Pediatric Nephrology. 27(10). 1901–1909. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by You Li Breakdown of academic impact, for papers by Lamia Heikal Breakdown of academic impact, for papers by Qianmei Wang Breakdown of academic impact, for papers by Yu Su Breakdown of academic impact, for papers by Mohammad Arshad Javed Shaikh Breakdown of academic impact, for papers by Sadat Dokaneheifard Breakdown of academic impact, for papers by Muhammad Zaeem Breakdown of academic impact, for papers by Xue Fan Breakdown of academic impact, for papers by Caixia Lin
Rankless by CCL
2026